Here are the S-3 shelf registrations from Oncolytics Biotech, Inc. (ONCY) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An S-3 covers the shelf registration that lets an established company sell over time, so if you follow ONCY and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ONCY filings page.
Oncolytics Biotech Inc. filed a shelf registration on Form S-3 to offer up to $250,000,000 of securities, including common stock, preferred stock, warrants, purchase contracts and units. The filing also re-registers $139.0 million of unsold securities from a prior Form F-3 under Rule 415(a)(6). The prospectus is a base shelf: specific terms, amounts and prices for each offering will be provided in future prospectus supplements.